“A 92 Day Toxicity Study of E7727 Administered via Oral Gavage in Cynomolgus Monkeys Followed by a 21 Day Recovery”
✓ VerifiedFDA multi-discipline review, p. 55Source ↗
Pivotal GLP studies
13-week/4-cycle oral cedazuridine studies in mouse and monkey
“Cedazuridine monotherapy was assessed in repeat-dose toxicity studies up to 13-weeks/4-cycles in duration in mice (up to 1000 mg/kg/dose) and cynomolgus monkeys (up to 200 mg/kg/dose).”
✓ VerifiedFDA multi-discipline review, p. 37Source ↗
Route in tox
Oral, in 5-days-on/23-days-off cycles mirroring the clinical regimen
“The pivotal studies were conducted under GLP-compliance, and the test articles were administered by the oral route following dosing regimens comparable to the planned clinical treatment cycle of 5 consecutive dosing days followed by 23 non-dosing days.”
✓ VerifiedFDA multi-discipline review, p. 37Source ↗